Results 11 to 20 of about 2,115 (174)

Cáncer de ovario [PDF]

Oncología, 2022
El diagnóstico y tratamiento de un crecimiento ovárico constituye un problema mayor ante el cual se enfrenta el médico en la actualidad. Poco progreso ha sido hecho en los métodos para el diagnóstico temprano; las formas disponibles de tratamiento no ha
Jorge Valencia, Vinicio Balseca
doaj   +2 more sources

The current therapeutic strategies in ovarian cancer treatment

Revista Información Científica, 2023
Introduction: ovarian cancer is one of the most common and lethal tumor in women. This happens as a result of late-stage cancer detention and an increased chemoresistance to standard therapy.
Carmita Lemus-Valdés, Alejandro Padrón-Albertus   +1 more
doaj   +3 more sources

Cáncer de ovario durante el embarazo

Revista Clínica de la Escuela de Medicina UCR-HSJD, 2014
El cáncer durante el embarazo implica una difícil situación en la que hay que velar por dos vidas. Anteriormente el tratamiento oncológico se consideraba incompatible con el desarrollo normal del feto y se recurría a tratamientos tardíos o terminación ...
Manuel Arce von Herold, Kenneth Loáiciga Vega   +1 more
doaj   +3 more sources

Caracterización clínico-epidemiológica del cáncer de ovario

Revista Finlay, 2021
Fundamento: el cáncer de ovario constituye un problema de salud pública en Cuba y en el mundo por su elevada morbilidad y mortalidad. Objetivo: caracterizar las pacientes diagnosticadas con cáncer de ovario atendidas en el Servicio de Ginecología ...
Hailyn González Fernández, Rodolfo Arian Morales Yera, Sergio Marcelino Santana Rodríguez, Liena Reinoso Padrón, Bernardo Enrique Heredia Martínez   +4 more
doaj   +4 more sources

Cáncer de ovario

Cirugía del Uruguay, 1981
El cáncer de ovario es un frecuente proceso que encuentra el Cirujano General y que debe resolverlo de la mejor manera posible.
Mario Olazábal, Oscar Blanchard, Carlos Giampietro, José M Mainetti, José A Mautone, Hugo Méndez Aserito, Moisés Rearden, Ramón Rodríguez de Armas   +7 more
doaj   +2 more sources

Patient involvement in research within the Gynecological Cancer InterGroup: A call to action for a systematic approach: Results from a survey. [PDF]

Health Sci Rep, 2023
Abstract Background and Aims Involving patients in research, not only as trial subjects, is not a newly established practice. Over the last two decades, patient roles have gradually expanded to become active research contributors, creating a more patient‐centered research landscape.
Nohová I, Andrews J, Votan B, Miller A, Sehouli J, Berger R.   +5 more
europepmc   +2 more sources

Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT‐OV26/GOG‐3012 trial

Cancer, Volume 129, Issue 12, Page 1846-1855, 15 June 2023., 2023
Abstract Background The PRIMA/ENGOT‐OV26/GOG‐3012 (NCT02655016) trial was amended to prospectively evaluate the safety and efficacy of an individualized starting dose (ISD) regimen of niraparib for first‐line maintenance therapy in patients with newly diagnosed advanced ovarian cancer.
Mansoor R. Mirza, Antonio González‐Martín, Whitney S. Graybill, David M. O’Malley, Lydia Gaba, Oi Wah Stephanie Yap, Eva M. Guerra, Peter G. Rose, Jean‐François Baurain, Sharad A. Ghamande, Hannelore Denys, Emily Prendergast, Carmela Pisano, Philippe Follana, Klaus Baumann, Paula M. Calvert, Jacob Korach, Yong Li, Izabela A. Malinowska, Divya Gupta, Bradley J. Monk   +20 more
wiley   +1 more source

Top advances of the year: Cervical cancer

Cancer, Volume 129, Issue 5, Page 657-663, 1 March 2023., 2023
Abstract Cervical cancer continues to affect women in the United States and throughout the world despite an effective vaccine against human papillomavirus and cancer screening programs. For the women who develop cervical cancer, surgery, radiation, and chemotherapy have been the mainstays of treatment for years.
Sarah E. Podwika, Linda R. Duska
wiley   +1 more source

Sinonasal inverted papilloma – malignant transformation and non‐sinonasal malignancies

The Laryngoscope, Volume 133, Issue 3, Page 506-511, March 2023., 2023
Objectives To assess malignant transformation rate, non‐sinonasal malignancies, and factors contributing to recurrence in patients treated for sinonasal inverted papilloma (SNIP). Study Design Retrospective study. Methods We retrospectively reviewed medical records of all patients treated for SNIP (n = 296) between the years 1984–2014 at Helsinki ...
Sanna Viitasalo, Taru Ilmarinen, Leena‐Maija Aaltonen, Jaana Hagström, Maija Hytönen, Sari Hammarén‐Malmi, Petra Pietarinen, Pia Järvenpää, Teemu Kinnari, Ahmed Geneid, Markus Lilja   +10 more
wiley   +1 more source

Benign descriptors and ADNEX in two‐step strategy to estimate risk of malignancy in ovarian tumors: retrospective validation in IOTA5 multicenter cohort

Ultrasound in Obstetrics &Gynecology, Volume 61, Issue 2, Page 231-242, February 2023., 2023
ABSTRACT Objective Previous work has suggested that the ultrasound‐based benign simple descriptors (BDs) can reliably exclude malignancy in a large proportion of women presenting with an adnexal mass. This study aimed to validate a modified version of the BDs and to validate a two‐step strategy to estimate the risk of malignancy, in which the modified ...
C. Landolfo, T. Bourne, W. Froyman, B. Van Calster, J. Ceusters, A. C. Testa, L. Wynants, P. Sladkevicius, C. Van Holsbeke, E. Domali, R. Fruscio, E. Epstein, D. Franchi, M. J. Kudla, V. Chiappa, J. L. Alcazar, F. P. G. Leone, F. Buonomo, M. E. Coccia, S. Guerriero, N. Deo, L. Jokubkiene, L. Savelli, D. Fischerova, A. Czekierdowski, J. Kaijser, A. Coosemans, G. Scambia, I. Vergote, D. Timmerman, L. Valentin   +30 more
wiley   +1 more source